China Inherited Ventricular Arrhythmias Registry
ConditionVentricular Arrythmia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-90
SponsorChina National Center for Cardiovascular Diseases
About this trial
This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
diagnosed as Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) or Catecholaminergic polymorphic ventricular tachycardia(CPVT).
Disqualifiers
patients were enrolled by other clinical trials.
Trial population
In 10 major arrhythmia centers distributed in 6 areas in China, 500 patients satisfying the inclusion criteria will be enrolled consecutively
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
sustained tachycardia/ ventricular fibrillation or sudden cardiac death
event of sustained ventricular tachycardia/ ventricular fibrillation or sudden cardiac death
Time frame
5 yearsSecondary outcomes
1
episodes of arrhythmia
type of arrhythmia, the amount of episodes, duration, unstable hemodynamics, treatment
Time frame
5 years2
all-cause death
exclude accidents, like trauma, drowning
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
China National Center for Cardiovascular Diseases
Lead sponsor
Renmin Hospital of Wuhan University
Collaborator
The First Affiliated Hospital with Nanjing Medical University
Collaborator
Second Affiliated Hospital of Nanchang University
Collaborator
Sir Run Run Shaw Hospital
Collaborator
West China Hospital
Collaborator
Beijing Anzhen Hospital
Collaborator
General Hospital of Shenyang Military Region
Collaborator
Xuzhou Central Hospital
Collaborator
First Affiliated Hospital, Sun Yat-Sen University
Collaborator
Source ClinicalTrials.gov